Fargo, NDNCT07230860Now EnrollingIRB Ready

Dermatitis, Atopic Clinical Trial in Fargo, ND

Access cutting-edge dermatitis, atopic treatment through this clinical trial at a research site in Fargo. Study-provided care at no cost to qualified participants.

Sponsored by Janssen Research & Development, LLC

Quick Self-Assessment

See if you qualify for this Fargo location

Preparing your pre-screening questions…

Expert Care in Fargo

Access dermatitis, atopic specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dermatitis, atopic treatment provided free

Apply for This Fargo Location

Check if you qualify for this dermatitis, atopic clinical trial in Fargo, ND

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fargo

    Convenient for ND residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fargo site if eligible
  4. 4Begin participation

About This Dermatitis, Atopic Study in Fargo

The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD).

Sponsor: Janssen Research & Development, LLC

Who Can Participate

Inclusion Criteria

Be otherwise healthy on the basis of physical examination, medical history, vital signs, and 12-lead electrocardiogram (ECG) performed at screening
Meets all the following disease activity criteria: a. Chronic atopic dermatitis (AD), according to American Academy of Dermatology Consensus Criteria with onset of symptoms at least 1 year prior to screening visit; b. Eczema area and severity index (EASI) score greater than or equal to (\>=) 16 at the screening and Week 0; c. validated investigator global assessment for atopic dermatitis (vIGA-AD) score \>= 3 at screening and Week 0; d. \>= 10% body surface area (BSA) of AD involvement at screening and Week 0; e. Documented history (within 6 months before screening) of either inadequate response or inadvisability to medicated topical treatments for AD or inadequate response to systemic therapies (within 12 months before screening)
Must sign an informed consent form (ICF) indicating that the participant understands the purpose of, and procedures required for, the study and is willing to participate in the study
If willing to participate in the substudy, must sign a separate ICF for the corresponding substudy (or substudies)
Willing and able to comply with scheduled visits, treatment plan, laboratory tests, lifestyle restrictions, and other study procedures

Exclusion Criteria

History of substance abuse or alcohol abuse within 1 year before screening
In the investigator's opinion, any clinically significant results from the 12-lead ECG, chemistry, hematology, or urinalysis laboratory tests obtained at the screening visit that would affect interpretation of study data or the participant's safety in the study
Known or suspected immunodeficiency, including history of invasive opportunistic infections
Previously received JNJ-95597528
Has known hypersensitivity or intolerance to JNJ-95597528 or its excipients or to any biologic medication or known allergies, or clinically significant reactions to murine, chimeric, monoclonal antibodies (mAbs), or antibody fragments

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fargo?

Yes, this clinical trial (NCT07230860) has an active research site in Fargo, ND that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dermatitis, Atopic Treatment Options in Fargo, ND

If you're searching for dermatitis, atopic treatment options in Fargo, ND, this clinical trial (NCT07230860) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fargo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dermatitis, atopic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dermatitis, atopic clinical trials near you to find additional studies recruiting in your area.

More Atopic Dermatitis Trials in Fargo, ND

See all atopic dermatitis clinical trials recruiting in Fargo — not just this study.

Browse Atopic Dermatitis Trials in Fargo →

Browse More Trials by Condition

Atopic Dermatitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Fargo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fargo, ND